Bio

Ali Etemadi, MD, is a postdoctoral scholar in the Division of Nephrology. His current work focuses on applying causal machine learning to derive clinically relevant inferences from claims-based registries, with a particular emphasis on cardiovascular outcomes in patients with chronic kidney disease.

Stanford Advisors

Contact

  • Academic
    aetemadi@stanford.edu
    University - Scholar Department: School of Medicine Position: Postdoctoral Scholar

Additional Info

Current Research and Scholarly Interests

I am a clinician and data scientist focusing on drawing causal inferences from observational data when randomized controlled trials are not feasible. Currently, my work centers on patients with late-stage chronic kidney disease, a rapidly growing population for which evidence is limited due to their frequent exclusion from RCTs. At the moment, I aim to move towards precision medicine approaches to optimize outcomes for these patients.

All Publications

  • Association between sleep duration and hypertension incidence: Systematic review and meta-analysis of cohort studies PLOS ONE Hosseini, K., Soleimani, H., Tavakoli, K., Maghsoudi, M., Heydari, N., Farahvash, Y., Etemadi, A., Najafi, K., Askari, M. K., Gupta, R., Hakim, D., Rahimi, K. 2024; 19 (7): e0307120

    Abstract

    Sleep duration has been suggested to be associated with hypertension (HTN). However, evidence of the nature of the relationship and its direction has been inconsistent. Therefore, we performed a meta-analysis to assess the relationship between sleep duration and risk of HTN incidence, and to distinguish more susceptible populations.PubMed, Embase, Scopus, Web of Science, and ProQuest were searched from January 2000 to May 2023 for cohort studies comparing short and long sleep durations with 7-8 hours of sleep for the risk of HTN incidence. Random-effect model (the DerSimonian-Laird method) was applied to pool risk ratios (RR) and 95% confidence interval (CI).We included sixteen studies ranging from 2.4 to 18 years of follow-up duration evaluating HTN incidence in 1,044,035 people. Short sleep duration was significantly associated with a higher risk of developing HTN (HR: 1.07, 95% CI: 1.06-1.09). The association was stronger when the sleep duration was less than 5 hours (HR: 1.11, 95% CI: 1.08-1.14). In contrast to males, females (HR: 1.07, 95% CI: 1.04-1.09) were more vulnerable to developing HTN due to short sleep duration. No significant difference between different follow-up durations and age subgroups was observed. Long sleep duration was not associated with an increased incidence of HTN.Short sleep duration was associated with higher risk of HTN incidence, however, there was no association between long sleep duration and incidence of HTN. These findings highlight the importance of implementing target-specific preventive and interventional strategies for vulnerable populations with short sleep duration to reduce the risk of HTN.

    View details for DOI 10.1371/journal.pone.0307120

    View details for Web of Science ID 001282347100032

    View details for PubMedID 39008468

    View details for PubMedCentralID PMC11249221

  • Revisiting Antioxidants in CKD: Still No Consensus. American journal of kidney diseases : the official journal of the National Kidney Foundation Etemadi, A., Chang, T. I. 2024

    View details for DOI 10.1053/j.ajkd.2024.06.009

    View details for PubMedID 38992459

https://orcid.org/0000-0002-7246-1370